Whether Probiotics Use in Neonate and Infant Improve Their Mother's Life Quality

NCT ID: NCT04741971

Last Updated: 2021-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-18

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postpartum depression and poor quality of life during postpartum were an vital issue in recent years. Infant's health condition was thought to be a possible reasons related mother's postpartum quality of life, and functional gastrointestinal disorders such as infantile colic and regurgitation were common problem during infant period. Previous study revealed that probiotics may improve the infant's discomfort caused by functional gastrointestinal disorders. Thus, this study aimed to investigate whether probiotics use in neonate and infant improve their mother's life quality?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is single blinded intervention study. The investigators will invite mother to participate in the project after giving birth. At week 0, mother who meet the eligibility criteria will be randomized in a single-blind study in a 1:1 ratio to probiotics with Vit. D3 (five drops per day) or Vit. D3 (placebo) (single drop per day) for 90 days. The follow-up will be at the 1, 3 and 6 months all the subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Depression Quality of Life Functional Gastrointestinal Disorders Probiotics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotics group

Will give Probiotics with Vit.D 3

Group Type EXPERIMENTAL

Probiotics group

Intervention Type DIETARY_SUPPLEMENT

Will give Probiotics with Vitamin D3 one drop per day for 90 days

Non-probiotics group

Will give Vit. D3 as placebo

Group Type PLACEBO_COMPARATOR

Non-probiotics group

Intervention Type DIETARY_SUPPLEMENT

Will give Vitamin D3 five drops per day for 90 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Probiotics group

Will give Probiotics with Vitamin D3 one drop per day for 90 days

Intervention Type DIETARY_SUPPLEMENT

Non-probiotics group

Will give Vitamin D3 five drops per day for 90 days

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age more than 37 to less than 41 weeks
* Age less than 1 week on entry into the study
* Birth weight adequate for gestational age
* Apgar score of more than 8 at 10 minutes


* Aged between 20-50 and baby included in our study

Exclusion Criteria

* Congenital disorders and/or clinical or physical alterations at clinical examination
* Antibiotic or probiotic administration before inclusion
* Admission to ICU

\<Participants of neonates' mother\>


* Diagnosed as psychiatric disease during antepartum period or before pregnancy
Minimum Eligible Age

1 Day

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Buddhist Tzu Chi General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-Chao Hsiao

Co-Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Hsun Chang

Role: STUDY_CHAIR

Department of Pediatrics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu-Chao Hsiao

Role: CONTACT

886-3-8561825 ext. 12777

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P00001711

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cesarean Section Study
NCT01992497 COMPLETED NA
Probiotic for Infants
NCT07054216 RECRUITING NA
Probiotics Strains for Infant Colic
NCT05685030 UNKNOWN PHASE2
Probiotics for Preterm Infants
NCT06885944 NOT_YET_RECRUITING
Infant Microbiota and Probiotic Intake Study
NCT02457338 ACTIVE_NOT_RECRUITING NA